Rhythmlink Announces Investment Partnership With Graham Partners | National business

COLUMBIA, SC-(BUSINESS WIRE)–March 17, 2023–

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing enterprises.

As a market-leading designer and manufacturer of disposable neurodiagnostic devices and supplies, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues alongside the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023.

“We are excited about this next phase of Rhythmlink,” said Sean Regan, CEO and co-founder. “Graham is an excellent partner for us because of their expertise in medical technology and healthcare, and we see this as a growth opportunity to continue to innovate beyond our current capabilities,” Regan said. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to grow our business without sacrificing what’s important to us – improving patient care in our neurodiagnostic field.”

This new relationship with Graham follows Rhythmlink’s highly successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. In partnership with New Heritage, Rhythmlink has grown rapidly, acquired Chalgren Enterprises and expanded its existing product line , to include EMG and NCV diagnostic consumables. Joe Strachek, Rhythmlink’s COO and CFO, spoke about the success of this relationship.

“Our partnership with New Heritage has been extremely beneficial,” Strachek said. “With their support, both financial and strategic, we have been able to realize significant growth, especially with the acquisition of Chalgren. We are extremely grateful for their partnership and guidance over the past four years.”

Rhythmlink sells a full line of neurodiagnostic device supplies for critical care, electroencephalography, intraoperative neuromonitoring, emergency and intensive care, and long-term epilepsy monitoring. More information about their products can be found online at www.Rhythmlink.com.

About Rhythmlink

Rhythmlink International is a medical device company specializing in devices that help connect patients to machines to record or retrieve physiological information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term epilepsy monitoring and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink improves patient care worldwide by transforming medical device technology that connects patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services.

About Graham Partners

Graham Partners is a private equity firm focused on investing in technology-driven companies that drive innovation in advanced manufacturing that leads to product substitution, raw material transformation and disruption to traditional end markets. Graham Partners can offer control or minority equity solutions and typically targets companies with EBITDA up to $50 million. Since the firm’s founding in 1988 by Stephen Graham, Graham Partners has completed more than 150 acquisitions, joint ventures, financings and divestitures. Committed capital raised since inception through Graham Partners funds together with Graham-led co-investments totaled approximately $4.0 billion as of December 31, 2022, differing from Graham’s regulatory assets under management of approximately 2.2 billion as of December 31, 2022. Investors include high net worth individuals, college and university endowments, foundations, public and private pension plans, funds of funds and other institutional investors. Based in the suburbs of Philadelphia, the firm has access to extensive operational resources and industry expertise and is a member of The Graham Group, an alliance of independent Graham Partners Inc. businesses, investment firms and philanthropic organizations that all share the common legacy of entrepreneur Donald Graham. www.grahampartners.net

For New Heritage Capital

Heritage is a Boston-based private equity firm with a twenty-year history of partnering with growing, founder-owned middle market businesses. With its innovative investment structures such as Private IPO ®, Heritage provides founders with a combination of liquidity and growth capital while allowing founders to maintain control of their business. With decades of growth management experience, Heritage provides its partners with strategic, operational and financial guidance to help their companies achieve their growth goals. For more information, please visit: www.newheritagecapital.com.

See source version on businesswire.com: https://www.businesswire.com/news/home/20230317005273/en/

CONTACT: Sean Regan

[email protected]

866.633.3754 [803.252.1222] office

803.252.1111 [fax]

KEYWORD: UNITED STATES NORTH AMERICA CANADA PENNSYLVANIA SOUTH CAROLINA

INDUSTRY KEYWORD: GENERAL HEALTH PROFESSIONAL SERVICES MEDICAL DEVICES HOSPITALS OTHER MANUFACTURING HEALTH TECH ENGINEERING BIOTECH NEUROLOGY FINANCING MANUFACTURING HEALTH

SOURCE: Rhythmlink International, LLC

Copyright Business Wire 2023.

PUBLICATION: 03/17/2023 12:52 PM/DISC: 03/17/2023 12:52 PM

http://www.businesswire.com/news/home/20230317005273/en

Leave a Comment

Your email address will not be published. Required fields are marked *